Patents by Inventor Maria Michejda
Maria Michejda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9540427Abstract: A peptide or peptidomimetic comprising the amino acid sequence of the second helix of a STAT protein, or a variant of such sequence, wherein the peptide or peptidomimetic comprises about 40 or fewer amino acids and binds to a STAT protein, as well as a method of inhibiting a STAT protein in a cell, a method of treating or preventing a disease associated with STAT overexpression in a host, and related compounds, compositions, and methods.Type: GrantFiled: May 30, 2008Date of Patent: January 10, 2017Assignee: The United States of America, as represented by the Secretary, Department of Health & Human ServicesInventors: Nadya I. Tarasova, Olga Timofeeva, Vadim Gaponenko, Christopher J. Michejda, Maria Michejda, Alan O. Perantoni, Sergey G. Tarasov
-
Patent number: 9085604Abstract: A novel antiproliferative factor comprising a glycopeptide is disclosed. In specific embodiments, the novel antiproliferative factor is associated with the bladder. Compositions, diagnostic kits and reagents, and methods of using the compounds for identifying and/or treating interstitial cystitis and cancer are disclosed.Type: GrantFiled: December 13, 2007Date of Patent: July 21, 2015Assignees: University of Maryland, Baltimore, The United States of America as represented by the Secretary of the Department of Health and Human Services, The United Sates of America as Represented by the Department of Veterans AffairsInventors: Susan K. Keay, Zoltan Szekely, Thomas Conrads, Timothy Veenstra, Maria Michejda
-
Patent number: 9079936Abstract: Derivatives of a novel antiproliferative factor comprising a glycopeptide is disclosed. In specific embodiments, the novel antiproliferative factor is associated with the bladder. Compositions, diagnostic kits and reagents, and methods of using the compounds for identifying and/or treating interstitial cystitis and cancer are disclosed. In particular embodiments, the glycopeptide comprises D-proline.Type: GrantFiled: August 18, 2009Date of Patent: July 14, 2015Assignees: University of Maryland, Baltimore, The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, The United States of America as Represented by the Department of Veterans AffairsInventors: Susan K. Keay, Zoltan Szekely, Maria Michejda
-
Patent number: 8912146Abstract: Derivatives of bladder epithelial antiproliferative factor and methods of using them are disclosed. In specific embodiments, the glycopeptide compositions are useful for the treatment and/or prevention of medical conditions, including cancer. In other embodiments, there are compositions and methods related to treatment of bladder conditions. In particular embodiments, the glycopeptide comprises D-pipecolic acid or L-pipecolic acid.Type: GrantFiled: August 18, 2009Date of Patent: December 16, 2014Assignees: University of Maryland, Baltimore, The Department of Health and Human Services, The United States of America as Represented by the Department of Veterans AffairsInventors: Susan K. Keay, Zoltan Szekely, Piotr Kaczmarek, Maria Michejda
-
Patent number: 8680056Abstract: A novel antiproliferative factor comprising a glycopeptide is disclosed. In specific embodiments, the novel antiproliferative factor is associated with the bladder. Compositions, diagnostic kits and reagents, and methods of using the compounds for identifying and/or treating interstitial cystitis and cancer are disclosed.Type: GrantFiled: May 3, 2007Date of Patent: March 25, 2014Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, University of Maryland, Baltimore, The United States of America as Represented by the Department of Veterans AffairsInventors: Susan K. Keay, Zoltan Szekely, Thomas Conrads, Timothy Veenstra, Maria Michejda
-
Publication number: 20120094933Abstract: Derivatives of bladder epithelial antiproliferative factor and methods of using them are disclosed. In specific embodiments, the glycopeptide compositions are useful for the treatment and/or prevention of medical conditions, including cancer. In other embodiments, there are compositions and methods related to treatment of bladder conditions. In particular embodiments, the glycopeptide comprises D-pipecolic acid or L-pipecolic acid.Type: ApplicationFiled: August 18, 2009Publication date: April 19, 2012Inventors: Christopher Michejda, Maria Michejda, Susan K. Keay, Zoltan Szekely, Piotr Kaczmarek
-
Patent number: 8008316Abstract: An azonafide-based compound of Formula I, a composition comprising the compound, and a method of using the compound to deliver a cytotoxic azonafide derivative to a cell, as well as related compounds and methods for the use thereof to pre-pare an azonafide-based compound of Formula I.Type: GrantFiled: September 12, 2007Date of Patent: August 30, 2011Assignee: The United States of America as represented by the Secretary, Department of Health and Human ServicesInventors: Nadya I. Tarasova, Marcin Dyba, Christopher J. Michejda, Maria Michejda, legal representative
-
Patent number: 7883698Abstract: The present invention is directed to compositions of fetal hematopoietic stem and progenitor cells and stromal (mesencymal) cells derived from second trimester (16-20 weeks gestation) miscarriages, that are isolated, processed and cryopreserved, and the therapeutic uses of such stem and progenitor cells upon application. Such compositions may be useful for hematopoietic reconstitution and/or replacement in patients with various diseases and metabolic disorders. The invention also relates to methods for collecting, isolating, processing and cryopreserving of the fetal stem and progenitor cells of the invention. Importantly, the invention meets an urgent need in regenerative medicine while at the same time ensures utility of the product compositions because it utilizes fetal materials from second trimester (16-20 weeks of gestation) spontaneously lost pregnancies which are free of moral or ethical burdens.Type: GrantFiled: January 17, 2007Date of Patent: February 8, 2011Inventor: Maria Michejda
-
Publication number: 20100184697Abstract: A peptide or peptidomimetic comprising the amino acid sequence of the second helix of a STAT protein, or a variant of such sequence, wherein the peptide or peptidomimetic comprises about 40 or fewer amino acids and binds to a STAT protein, as well as a method of inhibiting a STAT protein in a cell, a method of treating or preventing a disease associated with STAT overexpression in a host, and related compounds, compositions, and methods.Type: ApplicationFiled: May 30, 2008Publication date: July 22, 2010Applicant: THE U.S OF AMERICA, AS REPRESENTED BY THE SECRETARInventors: Nadya I. Tarasova, Olga Timofeeva, Vadim Gaponenko, Christopher J. Michejda, Maria Michejda, Alan O. Perantoni, Sergey G. Tarasov
-
Publication number: 20100120817Abstract: An azonafide-based compound of Formula I, a composition comprising the compound, and a method of using the compound to deliver a cytotoxic azonafide derivative to a cell, as well as related compounds and methods for the use thereof to pre-pare an azonafide-based compound of Formula I.Type: ApplicationFiled: September 12, 2007Publication date: May 13, 2010Applicant: Office of Technology Transfer, NIHInventors: Nadya I. Tarasova, Marcin Dyba, Christopher J. Michejda, Maria Michejda
-
Publication number: 20100041588Abstract: Derivatives of a novel antiproliferative factor comprising a glycopeptide is disclosed. In specific embodiments, the novel antiproliferative factor is associated with the bladder. Compositions, diagnostic kits and reagents, and methods of using the compounds for identifying and/or treating interstitial cystitis and cancer are disclosed. In particular embodiments, the glycopeptide comprises D-proline.Type: ApplicationFiled: August 18, 2009Publication date: February 18, 2010Inventors: Susan K. Keay, Christopher Michejda, Maria Michejda, Zoltan Szekely
-
Publication number: 20090148505Abstract: A novel antiproliferative factor comprising a glycopeptide is disclosed. In specific embodiments, the novel antiproliferative factor is associated with the bladder. Compositions, diagnostic kits and reagents, and methods of using the compounds for identifying and/or treating interstitial cystitis and cancer are disclosed.Type: ApplicationFiled: December 13, 2007Publication date: June 11, 2009Applicant: University of MarylandInventors: Susan K. Keay, Christopher Michejda, Zoltan Szekely, Thomas P. Conrads, Timothy D. Veenstra, Maria Michejda
-
Patent number: 7504430Abstract: The present invention features maleiimide compounds, pharmaceutical compositions of maleiimide compounds and methods of treating a patient suffering from cancer, the method comprising administering to a patient one or more maleiimide compounds of the invention.Type: GrantFiled: August 22, 2006Date of Patent: March 17, 2009Assignee: The United States of America as represented by the Secretary, Department of Health and Human ServicesInventors: Maria Michejda, legal representative, Wei Yao, Brian I. Carr, Siddhartha Kar, Christopher J. Michejda
-
Publication number: 20080171019Abstract: The present invention is directed to compositions of fetal hematopoietic stem and progenitor cells and stromal (mesencymal) cells derived from second trimester (16-20 weeks gestation) miscarriages, that are isolated, processed and cryopreserved, and the therapeutic uses of such stem and progenitor cells upon application. Such compositions may be useful for hematopoietic reconstitution and/or replacement in patients with various diseases and metabolic disorders. The invention also relates to methods for collecting, isolating, processing and cryopreserving of the fetal stem and progenitor cells of the invention. Importantly, the invention meets an urgent need in regenerative medicine while at the same time ensures utility of the product compositions because it utilizes fetal materials from second trimester (16-20 weeks of gestation) spontaneously lost pregnancies which are free of moral or ethical burdens.Type: ApplicationFiled: January 17, 2007Publication date: July 17, 2008Inventor: Maria Michejda
-
Publication number: 20080039518Abstract: The present invention features maleiimide compounds, pharmaceutical compositions of maleiimide compounds and methods of treating a patient suffering from cancer, the method comprising administering to a patient one or more maleiimide compounds of the invention.Type: ApplicationFiled: August 22, 2006Publication date: February 14, 2008Applicant: Government of the US, as represented by the Secretary, Department of Health and Human ServicesInventors: Christopher Michejda, Wei Yao, Brian Carr, Siddhartha Kar, Maria Michejda
-
Patent number: 4413985Abstract: A hydrocephalic drainage valve consisting of a hollow shank with a pointed conical tip. The shank has an intake port adjacent the conical tip. A ball check valve in the shank is urged by a coiled spring toward closing relationship with the port. A hollow set screw is adjustably mounted in the shank to vary the biasing force on the valve ball. In one form, for manual implantation, a sleeve is slidably mounted on the shank, has a centrally apertured enlarged head and has implantation enlarged threads near the head. The head has aligned opposite radial grooves which are engageable by a manual insertion tool. In other forms, for pneumatic insertion, the shank has an enlarged head, employed as a driving piston in a pneumatic insertion tube.Type: GrantFiled: November 30, 1981Date of Patent: November 8, 1983Assignee: The United States of America as represented by the Dept. of Health & Human ServicesInventors: Edward Wellner, Maria Michejda, Gary D. Hodgen